Patents by Inventor Mark Andrew ROSEN

Mark Andrew ROSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11937925
    Abstract: Independent component analysis may be performed on a plurality of detected electronic signals to separate signals within the detected electronic signals that are contributed by different sources. Each of the plurality of detected electronic signals may be received from a separate detector and may correspond to a detected optical signal emanating from a pregnant mammal's abdomen and a fetus contained therein. The detected optical signals may correspond to light that is projected into the pregnant mammal's abdomen from a light source. The separated signals may be analyzed to determine a separated signal that corresponds to light incident upon the fetus, which may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. An indication of the fetal hemoglobin oxygen saturation level may then be provided to the user.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: March 26, 2024
    Assignee: Raydiant Oximetry, Inc.
    Inventors: Neil Padharia Ray, Mark Andrew Rosen, Adam Jacobs, Kenneth Holt
  • Publication number: 20220361774
    Abstract: Systems, devices, and methods for performing trans-abdominal fetal oximetry and/or trans-abdominal fetal pulse oximetry using physiological characteristics and/or a calibration factor may receive a physiological characteristic of a pregnant mammal and determine one or more potential impact(s) of the physiological characteristic on a behavior of an optical signal projected into the abdomen of the pregnant mammal Then a calibration factor for the optical signal responsively to the impact. The calibration factor may then be used to calibrate a fetal detected electronic signal so that a level of fetal hemoglobin oxygen saturation may be determined.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 17, 2022
    Inventors: NEIL PADHARIA RAY, MARK ANDREW ROSEN, ADAM JACOBS, RODNEY P. CHIN, DAVID BOAS, JANA M. KAINERSTORFER, RUSSELL DELONZOR, DENISE ZARINS
  • Publication number: 20220354390
    Abstract: Independent component analysis may be performed on a plurality of detected electronic signals to separate signals within the detected electronic signals that are contributed by different sources. Each of the plurality of detected electronic signals may be received from a separate detector and may correspond to a detected optical signal emanating from a pregnant mammal's abdomen and a fetus contained therein. The detected optical signals may correspond to light that is projected into the pregnant mammal's abdomen from a light source. The separated signals may be analyzed to determine a separated signal that corresponds to light incident upon the fetus, which may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. An indication of the fetal hemoglobin oxygen saturation level may then be provided to the user.
    Type: Application
    Filed: July 20, 2022
    Publication date: November 10, 2022
    Inventors: Neil Padharia RAY, Mark Andrew ROSEN, Adam JACOBS, Kenneth HOLT
  • Publication number: 20220338739
    Abstract: Photoacoustic and/or acousto-optical techniques may be used to transabdominally perform fetal oximetry and/or trans-abdominal fetal pulse oximetry. In some cases, a composite acoustic signal that has emanated from an abdomen of a pregnant mammal may be received by a processor from, for example, an ultrasonic detector and/or microphone positioned on, or near, a pregnant mammal's abdomen and the composite acoustic signal may result from an optical signal incident on the pregnant mammal's abdomen and a fetus contained therein. A portion of the composite acoustic signal that was incident on the fetus may be isolated from the composite acoustic signal and then analyzed to determine a fetal hemoglobin oxygen saturation level and/or a fetal tissue oxygen saturation level.
    Type: Application
    Filed: September 16, 2020
    Publication date: October 27, 2022
    Inventors: JANA M. KAINERSTORFER, MARK ANDREW ROSEN, NEIL PADHARIA RAY
  • Patent number: 11419530
    Abstract: Independent component analysis may be performed on a plurality of detected electronic signals to separate signals within the detected electronic signals that are contributed by different sources. Each of the plurality of detected electronic signals may be received from a separate detector and may correspond to a detected optical signal emanating from a pregnant mammal's abdomen and a fetus contained therein. The detected optical signals may correspond to light that is projected into the pregnant mammal's abdomen from a light source. The separated signals may be analyzed to determine a separated signal that corresponds to light incident upon the fetus, which may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. An indication of the fetal hemoglobin oxygen saturation level may then be provided to the user.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: August 23, 2022
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventors: Neil Padharia Ray, Mark Andrew Rosen, Adam Jacobs, Kenneth Holt
  • Publication number: 20210251524
    Abstract: Fetal tissue oxygenation may be performed transabdominally by, for example, receiving a plurality of detected electronic signals that correspond to light emitted from a pregnant mammal's abdomen and a fetus contained therein that has been detected by the detector and converted into the detected electronic signal. An indication of a depth of the fetus within the pregnant mammal's abdomen may be received and a portion of the detected electronic signals that correspond to light that was incident upon the fetus may be isolated responsively to the indication of the depth of the fetus using, for example, time of flight of photons that correspond to the detected electronic signals. A fetal tissue oxygen saturation level may then be determined using the isolated portion of the detected electronic signals that correspond to light that was incident upon the fetus.
    Type: Application
    Filed: April 23, 2021
    Publication date: August 19, 2021
    Inventors: Neil Padharia RAY, Mark Andrew ROSEN, Adam JACOBS, Denise ZARINS, Kenneth HOLT, Jana M. KAINERSTORFER, David BOAS
  • Patent number: 10987036
    Abstract: Fetal tissue oxygenation may be performed transabdominally by, for example, receiving a plurality of detected electronic signals that correspond to light emitted from a pregnant mammal's abdomen and a fetus contained therein that has been detected by the detector and converted into the detected electronic signal. An indication of a depth of the fetus within the pregnant mammal's abdomen may be received and a portion of the detected electronic signals that correspond to light that was incident upon the fetus may be isolated responsively to the indication of the depth of the fetus using, for example, time of flight of photons that correspond to the detected electronic signals. A fetal tissue oxygen saturation level may then be determined using the isolated portion of the detected electronic signals that correspond to light that was incident upon the fetus.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: April 27, 2021
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventors: Neil Padharia Ray, Mark Andrew Rosen, Adam Jacobs, Denise Zarins, Kenneth Holt, Jana M Kainerstorfer, David Boas
  • Publication number: 20200359941
    Abstract: Independent component analysis may be performed on a plurality of detected electronic signals to separate signals within the detected electronic signals that are contributed by different sources. Each of the plurality of detected electronic signals may be received from a separate detector and may correspond to a detected optical signal emanating from a pregnant mammal's abdomen and a fetus contained therein. The detected optical signals may correspond to light that is projected into the pregnant mammal's abdomen from a light source. The separated signals may be analyzed to determine a separated signal that corresponds to light incident upon the fetus, which may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. An indication of the fetal hemoglobin oxygen saturation level may then be provided to the user.
    Type: Application
    Filed: December 28, 2018
    Publication date: November 19, 2020
    Inventors: Neil Padharia RAY, Mark Andrew ROSEN, Adam JACOBS, Kenneth HOLT
  • Publication number: 20200352487
    Abstract: A system and/or device for transabdominal fetal oximetry and/or fetal pulse oximetry and/or uterine tone determination may include one or more articulating, adjustable, and/or selectable components such as a light source and/or a photodetector. In some embodiments, the positioning of a light source and/or detector may be adjustable. The articulation and/or adjustment of position of the light source and/or photodetector may be in any plane (X, Y, and/or Z) and, in some instances, may be responsive to a fetal position within a maternal abdomen. Light detected by the detectors may be used to determine a fetal hemoglobin oxygen saturation level and/or a muscular state (e.g., contracted or relaxed) of the pregnant mammal's uterus.
    Type: Application
    Filed: December 28, 2018
    Publication date: November 12, 2020
    Applicant: Raydiant Oximetry, Inc.
    Inventors: Neil Padharia RAY, Mark Andrew ROSEN, Adam JACOBS, Nevan HANUMARA
  • Publication number: 20200323467
    Abstract: Fetal tissue oxygenation may be performed transabdominally by, for example, receiving a plurality of detected electronic signals that correspond to light emitted from a pregnant mammal's abdomen and a fetus contained therein that has been detected by the detector and converted into the detected electronic signal. An indication of a depth of the fetus within the pregnant mammal's abdomen may be received and a portion of the detected electronic signals that correspond to light that was incident upon the fetus may be isolated responsively to the indication of the depth of the fetus using, for example, time of flight of photons that correspond to the detected electronic signals. A fetal tissue oxygen saturation level may then be determined using the isolated portion of the detected electronic signals that correspond to light that was incident upon the fetus.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 15, 2020
    Inventors: Neil Padharia RAY, Mark Andrew ROSEN, Adam JACOBS, Denise ZARINS, Kenneth HOLT, Jana M KAINERSTORFER, David BOAS